Aldeyra Looking At Paths To Approval In Dry Eye After Phase III Miss

 
• By Joseph Haas
  
Blue eye detail
Aldeyra puts dry eye hopes on revised Phase III protocol
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D